The proposal also includes $9 million and 19 new full-time positions for the U.S. Food and Drug Administration to accelerate advanced pharmaceutical manufacturing.
The collaboration links site-specific conjugation technology with GMP manufacturing to support tech transfer, scale-up, and commercial production of ADCs.
